IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

Balance Sheet

Balance Sheet Decomposition
IRLAB Therapeutics AB

Current Assets 163.4m
Cash & Short-Term Investments 98.3m
Receivables 65.1m
Non-Current Assets 51.2m
PP&E 4.4m
Intangibles 46.9m
Other Non-Current Assets -1k
Current Liabilities 142.3m
Other Current Liabilities 142.3m
Non-Current Liabilities 2.6m
Long-Term Debt 2.6m

Balance Sheet
IRLAB Therapeutics AB

Rotate your device to view
Balance Sheet
Currency: SEK
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
14
26
75
134
111
277
402
253
111
Cash Equivalents
14
26
75
134
111
277
402
253
111
Total Receivables
1
1
2
4
8
5
11
10
9
Accounts Receivables
0
0
0
0
0
0
4
3
0
Other Receivables
1
1
2
4
0
0
6
7
0
Other Current Assets
1
1
2
2
2
2
9
6
3
Total Current Assets
16
28
78
140
120
284
421
269
124
PP&E Net
1
1
0
1
6
4
8
8
7
PP&E Gross
1
1
0
1
6
4
8
8
7
Accumulated Depreciation
0
1
1
1
3
5
8
12
16
Intangible Assets
84
84
84
83
82
82
43
47
47
Long-Term Investments
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
Total Assets
101
N/A
113
+12%
163
+44%
225
+38%
208
-7%
370
+78%
472
+28%
324
-32%
177
-45%
Liabilities
Accounts Payable
2
5
4
6
8
4
12
10
11
Accrued Liabilities
1
4
3
3
8
12
6
13
15
Short-Term Debt
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
2
2
3
4
3
Other Current Liabilities
2
0
1
3
5
4
48
5
8
Total Current Liabilities
5
9
8
12
23
21
69
32
37
Long-Term Debt
0
0
0
0
3
1
4
0
25
Deferred Income Tax
3
0
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
Total Liabilities
9
N/A
9
+2%
8
-14%
12
+56%
26
+111%
22
-15%
73
+229%
33
-55%
61
+87%
Equity
Common Stock
0
1
1
1
1
1
1
1
1
Retained Earnings
22
21
77
151
247
339
287
400
575
Additional Paid In Capital
70
124
231
363
428
686
685
690
690
Other Equity
0
0
0
0
0
0
0
0
0
Total Equity
92
N/A
104
+13%
155
+49%
212
+37%
182
-14%
348
+91%
399
+15%
291
-27%
116
-60%
Total Liabilities & Equity
101
N/A
113
+12%
163
+44%
225
+38%
208
-7%
370
+78%
472
+28%
324
-32%
177
-45%
Shares Outstanding
Common Shares Outstanding
18
26
36
41
44
48
52
52
52

See Also

Discover More